021-51111890
购物车（）
sales@molnova.cn
BRL-15572 dihydrochloride
CAS No. 193611-72-2
BRL-15572 dihydrochloride ( BRL15572;BRL 15572 )
产品货号. M13033 CAS No. 193611-72-2
BRL-15572 is a potent, selective h5-HT1D receptor antagonist.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥332 | 有现货 |
|
| 10MG | ￥535 | 有现货 |
|
| 25MG | ￥875 | 有现货 |
|
| 50MG | ￥1345 | 有现货 |
|
| 100MG | ￥2009 | 有现货 |
|
| 200MG | ￥3021 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称BRL-15572 dihydrochloride
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述BRL-15572 is a potent, selective h5-HT1D receptor antagonist.
-
产品描述BRL-15572 is a potent, selective h5-HT1D receptor antagonist with pKi of 7.9, dispalys 60-fold selectivity over h5-HT1B; shows binding affinities for 5-HT1A, 5-HT1B, 5-HT1E, 5-HT1F, 5-HT2A, 5-HT2B, 5-HT2C, 5-HT6 and 5-HT7 with pKi of 7.7, 6.1, 5.2, 6.0, 6.6, 7.4, 6.2, 5.9 and 6.3, respectively.
-
同义词BRL15572;BRL 15572
-
通路Endocrinology/Hormones
-
靶点5-HT Receptor
-
受体5-HT1A; 5-HT1D; 5-HT2A; 5-HT2B; 5-HT7
-
研究领域Neurological Disease
-
适应症——
化学信息
-
CAS Number193611-72-2
-
分子量479.87
-
分子式C25H29Cl3N2O
-
纯度>98% (HPLC)
-
溶解度10 mM in DMSO
-
SMILESC1CN(CCN1CC(C(C2=CC=CC=C2)C3=CC=CC=C3)O)C4=CC(=CC=C4)Cl.Cl.Cl
-
化学全称1-Piperazineethanol, 4-(3-chlorophenyl)-.alpha.-(diphenylmethyl)-, hydrochloride (1:2)
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Price GW, et al. Naunyn Schmiedebergs Arch Pharmacol. 1997 Sep;356(3):312-20.
2. Schlicker E, et al. Naunyn Schmiedebergs Arch Pharmacol. 1997 Sep;356(3):321-7.
3. De Vries P, et al. Eur J Pharmacol. 1998 Nov 27;362(1):69-72.
4. Marcoli M, et al. Br J Pharmacol. 1999 Feb;126(3):607-12.
2. Schlicker E, et al. Naunyn Schmiedebergs Arch Pharmacol. 1997 Sep;356(3):321-7.
3. De Vries P, et al. Eur J Pharmacol. 1998 Nov 27;362(1):69-72.
4. Marcoli M, et al. Br J Pharmacol. 1999 Feb;126(3):607-12.
产品手册
关联产品
-
17α-Estradiol
Endogenous estrogen receptor ligand (Kivalues are 0.2 and 1.2 nM for ERαand ERβreceptors respectively).
-
PHCCC
PHCCC is a Group I metabotropic glutamate receptor antagonist and a positive allosteric modulator of mGluR4. It also is a potent to antagonism for mGluR2 and mGluR8.
-
Cerlapirdine
Cerlapirdine is a selective, potent, full antagonist of the 5-hydroxytryptamine 6 (5-HT6) receptor. Cerlapirdine is already in clinical development for the treatment of cognitive disorders related to Alzheimer's disease and schizophrenia. It works by acting as a selective 5-HT6 receptor antagonist.
